Ocular Therapeutix: Strategiechef Sanjay Nayak tritt zum 16. Oktober 2026 zurück

• Sanjay Nayak, Chief Strategy Officer von Ocular Therapeutix, verlässt das Unternehmen mit Wirkung zum 16. Oktober 2026.
• Seinen Rücktritt kündigte er am 14. Oktober 2026 an. Er wechselt als Chief Executive Officer zu einem Unternehmen in Privatbesitz.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116617), on October 16, 2026, and is solely responsible for the information contained therein.